Doggrell, Sheila A <br/><br/>
A new approach to Parkinson's disease: inhibition of leucine-rich repeat kinase-2.  [electronic resource] 

 -  Expert opinion on investigational drugs  Apr 2011 
 - 587-90 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1744-7658 
<br/><br/><label>Standard No.: </label>10.1517/13543784.2011.550874  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antiparkinson Agents--pharmacology<br/>Cell Culture Techniques<br/>Cell Death--drug effects<br/>Corpus Striatum--drug effects<br/>Genetic Vectors--genetics<br/>Indoles--pharmacology<br/>Leucine-Rich Repeat Serine-Threonine Protein Kinase-2<br/>Mice<br/>Mutation<br/>Nerve Degeneration--drug therapy<br/>Oximes--pharmacology<br/>Parkinson Disease--drug therapy<br/>Phenols--pharmacology<br/>Phosphorylation--drug effects<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Rats<br/>Simplexvirus--genetics<br/>Tyrosine 3-Monooxygenase--metabolism